Is terbutaline appropriate for treating atrial fibrillation with a slow ventricular response?

Terbutaline is NOT appropriate for treating atrial fibrillation with slow ventricular response and should be avoided

Terbutaline is contraindicated in this clinical scenario. This beta-2 agonist will paradoxically worsen the situation by increasing heart rate and potentially triggering dangerous arrhythmias, which is the opposite of what you need in AF with slow ventricular response.

Why Terbutaline is Harmful in This Context

Terbutaline is a beta-adrenergic agonist that increases heart rate and cardiac automaticity 1. The FDA label explicitly warns that terbutaline "should be used with caution in patients with cardiovascular disorders, including cardiac arrhythmias" 1. More concerning, research demonstrates that terbutaline can:

• Trigger atrial fibrillation - Case reports document new-onset AF during terbutaline therapy 2
• Enhance digitalis-induced arrhythmias by 75%, triggering delayed afterdepolarizations 3
• Increase heart rate and alter cardiac conduction through beta-receptor stimulation 4

The Actual Problem: AF with Slow Ventricular Response

AF with slow ventricular response represents excessive AV nodal blockade or intrinsic conduction system disease. The ventricular rate is already too slow - you need to either:

1. Address the underlying cause (medication toxicity, high vagal tone, intrinsic AV node disease)
2. Consider temporary pacing if symptomatic bradycardia with hemodynamic compromise
3. Reduce or discontinue AV nodal blocking agents (beta-blockers, calcium channel blockers, digoxin, amiodarone)

What the Guidelines Actually Recommend

The major AF guidelines 5, 6, 7, 8 focus exclusively on rate control for rapid ventricular response, not slow response. They recommend:

• Beta-blockers (Class I) for rapid rates
• Calcium channel blockers (Class I) for rapid rates
• Digoxin or amiodarone (Class I) for rapid rates with heart failure

None of these guidelines mention using chronotropic agents like terbutaline for slow ventricular response in AF. This is because the standard approach is to remove offending medications and consider pacing, not to pharmacologically increase the rate with sympathomimetics.

Critical Pitfall to Avoid

Do not confuse AF with slow ventricular response with bradycardia requiring chronotropic support. While terbutaline increases heart rate in normal sinus rhythm, using it in AF risks:

• Accelerating the ventricular response unpredictably once AV nodal blockade is overcome
• Triggering ventricular arrhythmias 3
• Worsening the underlying AF burden 2

The Correct Management Approach

For symptomatic AF with slow ventricular response:

1. Stop all AV nodal blocking agents immediately
2. Assess for digoxin toxicity if patient is on digoxin (check level, electrolytes)
3. Evaluate for structural heart disease or sick sinus syndrome
4. Consider temporary transcutaneous or transvenous pacing if hemodynamically unstable
5. Permanent pacemaker evaluation if intrinsic conduction disease is present
6. Treat reversible causes (hypothyroidism, electrolyte abnormalities, hypothermia 9)

Terbutaline has no role in this algorithm and should never be used for AF with slow ventricular response.